CENX Stock Charts

Quarterly

Annual

Unit: USD	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30

cash flows from operating activities:
net income	10,600,000	-9,100,000	25,700,000	40,400,000	42,300,000	-6,700,000	244,700,000	25,600,000	-45,900,000	6,600,000	-38,600,000	-113,500,000	44,300,000	37,400,000	17,700,000	60,400,000	-52,400,000	-35,100,000	-140,000,000	-35,500,000	-58,200,000	-26,900,000	-2,700,000	-4,800,000	-20,700,000	-20,700,000	-34,600,000	-65,000,000	-20,300,000	19,400,000	-300,000	35,805,000	20,783,000	7,131,000	-15,139,000	-168,464,000	-58,273,000	-9,515,000	-16,163,000	-43,080,000	-56,112,000	-33,897,000	73,779,000	61,849,000	50,405,000	20,344,000	-20,104,000	-9,675,000	-4,318,000	-34,573,000	8,253,000	-6,909,000	-12,023,000	-12,277,000	-4,401,000	-31,107,000	-6,600,000	23,986,000	25,046,000	65,280,000	-16,787,000	5,146,000	6,332,000	-24,354,000	40,142,000	-107,146,000	-114,624,000	36,973,000	-2,341,000	-232,796,000	-112,303,000	7,470,000	-60,665,000	64,249,000	-119,123,000	173,939,000	45,800,000	-141,571,000	-148,658,000	-20,071,000	41,347,000	11,127,000	20,932,000	-16,049,000
adjustments to reconcile net income to net cash from operating activities:
unrealized loss on derivative instruments											64,400,000
depreciation, depletion and amortization	20,200,000	20,700,000	20,700,000	17,000,000	23,100,000	21,800,000	19,900,000	19,400,000
share-based compensation
loss on early extinguishment of debt																0	0			0																												0	0
change in deferred tax provision	-3,600,000	1,200,000	1,200,000
bargain purchase gain				0	0	0	-245,900,000
other non-cash items - net	-600,000			4,400,000	4,200,000	2,000,000	-1,500,000	4,600,000	-4,900,000	4,200,000	-500,000				-1,700,000	-4,300,000	-1,600,000	1,000,000	3,200,000	-2,400,000	-400,000	2,600,000	-700,000	0	-800,000	-600,000	-4,500,000	-9,200,000	4,200,000	-3,600,000	-4,600,000
change in operating assets and liabilities:
accounts receivable	-12,100,000
non-trade payables
manufacturing credit receivable	-25,400,000	-22,400,000	-20,700,000	-20,700,000	-48,100,000	-11,200,000	-12,600,000
due from affiliates	-1,900,000	-5,400,000	16,700,000	-13,200,000	-4,500,000	15,400,000	-2,600,000	-2,500,000	-800,000	-500,000	-11,700,000	9,200,000	3,100,000	1,600,000	-10,300,000	2,400,000	14,900,000	-4,400,000	-12,200,000	5,900,000	-6,700,000	1,400,000	20,200,000	-6,900,000	-1,800,000	2,700,000	-1,100,000	-2,300,000	-13,900,000	2,100,000	1,700,000	1,483,000	-1,354,000	1,294,000	4,862,000	-2,380,000	240,000	967,000	1,939,000	11,680,000	23,213,000	32,752,000	-53,559,000	20,950,000	1,642,000	2,037,000	-12,545,000	-18,632,000	9,000	18,597,000	-5,691,000	1,885,000	-5,084,000	5,650,000	-249,000	4,092,000	-4,663,000	2,499,000	8,766,000	-17,857,000	-3,663,000	4,089,000	-20,760,000	-1,385,000	-1,989,000	-1,905,000	26,904,000	-3,176,000	1,918,000	-8,513,000	1,001,000	10,305,000	-15,530,000	15,074,000	-9,342,000	-12,565,000	6,067,000	-3,064,000		-3,573,000	225,000	102,000		-287,000
inventories	-44,100,000	27,600,000	-100,000	3,200,000	-76,900,000	16,600,000	-7,200,000	-500,000	44,800,000	22,600,000	-41,100,000	-8,700,000	38,900,000	-42,100,000	-900,000	-82,300,000	-11,800,000	-28,600,000	-11,800,000	-27,800,000	3,900,000	18,800,000	-10,400,000	-1,300,000	14,600,000	-25,300,000	16,400,000	16,000,000	-36,500,000	-32,300,000	-10,000,000	-43,443,000	-7,145,000	-12,269,000	-4,677,000	2,184,000	-3,736,000	-15,177,000	17,648,000	91,288,000	14,239,000	-46,296,000	-14,335,000	-15,624,000	1,897,000	8,591,000	-11,377,000	1,108,000	-514,000	-19,606,000	-2,728,000	44,000	6,770,000	6,330,000	18,710,000	-12,550,000	8,195,000	-23,540,000	-7,924,000	-16,261,000	3,414,000	-2,022,000	-9,140,000	6,110,000	-1,484,000	26,379,000	4,761,000	-5,907,000	-17,410,000	-12,802,000	-5,090,000	944,000	-3,501,000	-18,433,000	560,000	-11,204,000	-1,351,000	-16,529,000		-1,758,000	1,706,000	5,128,000		1,669,000
prepaid and other current assets	200,000	-500,000	4,000,000	-8,600,000	-400,000	9,800,000	200,000	-1,900,000	-2,900,000	5,900,000	1,800,000	0	4,500,000	5,300,000	-4,200,000	-8,600,000	-500,000	-1,200,000	-3,100,000	1,600,000	100,000	-1,200,000	100,000	-1,100,000	1,700,000	-500,000	2,600,000	-2,700,000	2,700,000	-1,700,000	800,000	6,688,000	-2,726,000	-892,000	4,726,000	9,297,000	-3,500,000	-1,774,000	14,290,000	-3,579,000	-384,000	-2,141,000	5,960,000	357,000	-3,781,000	9,774,000	-2,958,000	10,210,000	1,100,000	80,000	-6,072,000	13,200,000	-4,377,000	1,489,000	-5,366,000	4,614,000	3,586,000	910,000	-29,901,000	-3,144,000	-3,867,000	16,731,000	3,692,000	-24,437,000	-8,607,000	3,704,000	74,187,000	20,432,000	-23,531,000	2,710,000		662,000	-1,433,000	-1,217,000	4,653,000	-1,105,000
accounts payable, trade	16,800,000	-2,800,000	20,800,000	-90,700,000	53,500,000	20,400,000	-33,800,000	25,700,000	27,800,000	-55,500,000	-17,400,000	-6,200,000	-57,100,000	15,900,000	31,600,000	-1,900,000	37,000,000	14,600,000	-4,900,000	32,600,000	-2,000,000	1,300,000	-11,300,000	-13,900,000	11,800,000	-12,900,000	-10,200,000	7,100,000	-4,600,000	22,600,000	5,400,000	175,000	5,518,000	3,430,000	-4,377,000	7,299,000	-4,009,000	4,964,000	-5,983,000	-17,098,000	-9,398,000	-15,579,000	-18,508,000	20,682,000	-472,000	-4,588,000	-3,825,000	-1,323,000	-4,149,000	28,432,000	2,264,000	-3,291,000	7,108,000	-4,489,000	-11,442,000	1,879,000	-1,581,000	3,528,000	-4,730,000	12,980,000	5,419,000	-4,502,000	-2,223,000	-6,336,000	13,508,000	-12,567,000	-12,201,000						-17,088,000	24,429,000										9,024,000
due to affiliates	4,900,000	-24,000,000	12,200,000	19,500,000	-2,200,000	-24,800,000	33,600,000	35,900,000	8,100,000	-2,700,000	10,400,000	-9,500,000	-5,200,000	-27,600,000	-1,200,000	-4,800,000	33,300,000	2,800,000	7,000,000	7,500,000	1,100,000	-27,800,000	-3,200,000	32,900,000	-13,200,000	10,100,000	-7,200,000	-6,300,000	14,300,000	-12,100,000	-6,000,000	3,310,000	-2,081,000	308,000	3,296,000	2,584,000	3,068,000	6,932,000	-5,372,000	-23,611,000	-30,011,000	13,633,000	27,773,000	-8,278,000	12,562,000	-22,024,000	20,798,000	-18,157,000	4,395,000	17,135,000	10,472,000	-2,928,000	-390,000	1,511,000	-360,000	-3,001,000	5,358,000	-3,112,000	-2,722,000	7,805,000	4,259,000	-5,980,000	6,601,000	6,191,000	-6,717,000	-3,398,000	-8,037,000	-223,248,000	-16,816,000	24,542,000	1,170,000	-3,456,000	10,093,000	5,381,000	6,572,000	956,000	13,379,000	-11,206,000		12,028,000	-402,000	-9,146,000		7,989,000
accrued and other current liabilities	4,500,000	10,000,000	-13,900,000	2,700,000	-3,400,000	7,900,000	-8,400,000		-5,000,000	11,700,000	-8,700,000	-3,700,000	-4,100,000	15,000,000	1,600,000	1,500,000	4,800,000	-5,100,000	3,800,000	-7,900,000	6,600,000	5,700,000	-5,600,000	-5,700,000	10,000,000	2,200,000	-3,800,000	-12,800,000	-500,000	-4,000,000	6,200,000	5,226,000	13,699,000	458,000	-4,905,000	-8,669,000	5,254,000	-1,738,000	1,253,000	-23,122,000	-9,706,000	-1,586,000	2,874,000	25,637,000	4,634,000	-5,580,000	-6,620,000	3,625,000	4,036,000	-9,365,000	7,538,000	-14,489,000	6,993,000	-5,253,000	7,003,000	-16,646,000	9,496,000	4,170,000	3,405,000	-4,576,000	5,007,000	-3,612,000	1,423,000	-8,390,000	51,000	2,778,000	-9,887,000	-22,979,000	13,430,000	-18,974,000	35,377,000	-35,434,000	-12,244,000	-4,611,000	25,346,000	62,862,000	-52,918,000	-16,325,000		-13,665,000	4,003,000	-7,951,000		-1,458,000
ravenswood retiree medical settlement
other - net	-7,600,000	1,000,000	-200,000	1,700,000	-1,300,000	2,500,000	1,000,000	1,800,000	600,000	-2,200,000	2,600,000				-4,300,000	800,000	5,300,000	-3,600,000	-700,000	-2,900,000	2,000,000	2,200,000	1,100,000	-1,500,000	-600,000	1,700,000	-600,000	7,600,000	-5,000,000	4,100,000	-3,800,000	-5,620,000	6,208,000	7,579,000	-3,585,000	1,102,000	1,456,000	2,190,000	-1,648,000																																			6,692,000		-3,474,000
net cash from operating activities	2,000,000	7,900,000	72,300,000	-41,400,000	20,100,000	11,500,000	-14,800,000	66,000,000	41,500,000	-1,700,000	-200,000	-31,300,000	-11,400,000	31,200,000	37,400,000	-52,600,000	75,800,000	-38,100,000	-49,800,000	9,600,000	-38,300,000	37,000,000	34,600,000	22,100,000	21,200,000	-4,100,000	-21,500,000	-10,100,000	-28,600,000	2,600,000	-33,000,000	1,092,000	47,574,000	14,437,000	-11,344,000	22,591,000	-8,021,000	8,700,000	14,903,000	-643,000	-77,807,000	-5,951,000	116,267,000	98,697,000	89,086,000	19,369,000	-10,741,000	-22,740,000	19,482,000	575,000	22,401,000	16,054,000	22,700,000	-6,513,000	4,898,000	-14,030,000	27,229,000	-12,505,000	-3,630,000	31,178,000	28,200,000	50,474,000	21,658,000	10,688,000	-17,961,000	-28,064,000	74,736,000	-134,054,000	305,963,000	58,850,000	34,985,000	-61,827,000	-77,031,000	98,118,000	67,843,000	50,220,000	51,251,000	16,039,000		68,500,000	31,659,000	27,065,000		20,253,000
cash flows from investing activities:
purchase of property, plant and equipment	-20,100,000	-23,800,000	-21,200,000	-13,200,000	-22,500,000	-16,900,000	-29,700,000	-32,300,000	-26,100,000	-22,300,000	-14,300,000	-16,100,000	-18,400,000	-25,800,000	-26,000,000	-37,300,000	-19,800,000	-18,500,000	-7,400,000	-1,900,000	-1,900,000	-3,600,000	-6,000,000	-19,700,000	-16,600,000	-12,700,000	-10,600,000	-33,700,000	-36,300,000	-9,500,000	-3,500,000	-8,249,000	-4,747,000	-9,798,000	-9,045,000	-8,817,000	-5,393,000	-3,899,000	-3,835,000	-16,625,000	-11,488,000	-15,627,000	-10,960,000	-14,694,000	-10,107,000	-7,058,000	-9,700,000	-14,539,000	-15,429,000	-7,201,000	-9,364,000	-7,278,000	-4,234,000	-3,266,000	-2,899,000	-9,232,000	-3,515,000	-4,225,000	-3,128,000		-2,366,000	-2,040,000	-972,000		-2,740,000	-2,743,000	-9,184,000	-11,777,000	-6,046,000	-8,915,000		-6,015,000	-5,240,000	-2,438,000
proceeds for joint venture partner's share of co-tenancy assets	4,000,000
proceeds from sale of assets					0
net cash from investing activities	-16,100,000	-18,100,000	-15,500,000	-500,000	-22,500,000	-14,600,000	-29,700,000	-40,200,000	-400,000	-2,900,000	-14,300,000	-15,400,000	-18,400,000	-25,700,000	-26,000,000	-36,900,000	-19,800,000	-18,500,000	-7,400,000		-1,900,000	-3,600,000	-5,900,000		-16,600,000	-2,200,000	-10,600,000			-9,500,000	-3,500,000	-8,217,000	-4,075,000	-9,856,000	4,793,000	-7,781,000	-3,770,000	-5,777,000	-3,835,000	-6,940,000	33,375,000	-36,159,000	-33,639,000	-69,119,000	-14,480,000	-10,606,000	-14,852,000	-23,248,000	-22,869,000	-60,151,000	-10,906,000	-5,453,000	-5,837,000	-19,520,000	-1,721,000	-11,879,000	-4,480,000	-1,357,000	-7,179,000	7,875,000	-19,221,000	-7,972,000	-6,153,000	-5,398,000	-15,733,000	-9,397,000	-15,685,000	-49,648,000	-60,819,000	-16,304,000	-19,605,000	-25,449,000	-34,504,000	-29,013,000	-41,595,000	-49,781,000	-45,159,000	-75,402,000		-91,093,000	-74,957,000	-51,469,000		-20,602,000
cash flows from financing activities:
repayment of senior notes due 2028
early redemption premiums paid
proceeds from issuance of senior notes due 2032
payment of deferred financing fees
borrowings under revolving credit facilities	126,100,000	329,100,000	257,600,000	326,000,000	111,500,000	142,000,000	155,900,000	81,700,000	167,400,000	215,400,000	192,400,000	216,000,000	313,800,000	332,300,000	264,100,000	334,600,000	217,300,000	229,300,000	197,600,000	85,300,000	51,200,000	600,000	121,800,000	73,500,000	26,400,000	118,600,000	169,600,000	105,800,000			300,000	259,000	302,000	487,000	233,000	279,000	305,000	224,000	371,000	323,000	404,000	555,000	455,000	692,000	5,085,000	67,776,000	18,870,000
repayments under revolving credit facilities	-129,200,000	-320,900,000	-300,100,000	-281,500,000	-102,000,000	-191,100,000	-130,500,000	-126,200,000	-235,400,000	-187,200,000	-209,400,000	-204,400,000	-250,400,000	-352,600,000	-307,400,000	-268,400,000	-209,500,000	-240,100,000	-192,200,000	-90,300,000	-91,200,000	-600,000	-35,800,000	-69,800,000	-34,200,000	-145,700,000	-157,600,000				-300,000	-259,000	-302,000	-487,000	-233,000	-279,000	-305,000	-224,000	-371,000	-323,000	-404,000	-555,000	-455,000	-692,000	-5,085,000	-67,776,000	-24,870,000
repayments under iceland term facility				0	0	0	-1,200,000
borrowings under grundartangi casthouse debt facility				0	0	0	25,000,000	15,000,000	20,000,000	10,000,000	10,000,000	10,000,000	0	0	40,000,000
repayments under grundartangi casthouse debt facility	-2,300,000	-2,200,000	-2,300,000
repayments under vlissingen credit facility
carbon credit proceeds								3,000,000
carbon credit repayments				0
net cash from financing activities	123,400,000	6,000,000	-44,800,000			-49,100,000	49,200,000	-30,200,000	-7,900,000	34,500,000	-9,400,000	36,200,000	63,300,000	-21,200,000	-3,900,000	61,300,000	2,700,000	39,300,000	400,000	-10,000,000	-52,500,000	-5,000,000	81,000,000	3,700,000	-7,800,000	9,800,000	15,400,000	9,200,000	14,300,000	100,000	100,000	123,000	41,000	197,000	43,000					0	0	-16,913,000	-19,439,000	254,000	-2,580,000	123,000	-5,997,000	-10,725,000	16,657,000			0	0	0	-4,033,000	-7,085,000	-38,755,000			0	0			-3,393,000	0	0	79,041,000	-38,887,000	950,000	2,042,000	-19,194,000	-35,675,000	131,138,000	2,654,000	20,023,000	20,480,000	5,571,000	59,123,000		43,266,000	25,709,000	32,999,000		1,654,000
change in cash, cash equivalents and restricted cash	109,300,000	-4,200,000	12,000,000		-7,400,000	-52,200,000	4,700,000		33,200,000	29,900,000	-23,900,000		33,500,000	-15,700,000	7,500,000		58,700,000	-17,300,000	-56,800,000		-92,700,000	28,400,000	109,700,000		-3,200,000	3,500,000	-16,700,000		-50,600,000	-6,800,000	-36,400,000
cash, cash equivalents and restricted cash, beginning of period	0	0	35,700,000				90,300,000		0	0	55,500,000		0	0	40,700,000		0	0	84,300,000		0	0	39,700,000		0	0	39,700,000		0	0	168,000,000
cash, cash equivalents and restricted cash, end of period	109,300,000	-4,200,000	47,700,000				95,000,000		33,200,000	29,900,000	31,600,000			-15,700,000	48,200,000			-17,300,000	27,500,000		-92,700,000	28,400,000	149,400,000		-3,200,000	3,500,000	23,000,000		-50,600,000	-6,800,000	131,600,000
unrealized gain on derivative instruments		11,500,000	3,000,000					2,900,000	17,900,000
non-trade receivables		-3,800,000	15,400,000	24,400,000	8,700,000	-6,800,000	5,200,000
accounts receivable - net			-12,500,000	-2,400,000	21,500,000	-36,000,000	-1,400,000	15,500,000	-4,600,000	6,900,000	19,100,000				-47,100,000	11,400,000	-11,600,000	-9,600,000	-6,400,000	-400,000	-14,600,000	16,900,000	17,200,000	1,700,000	10,000,000	9,100,000	-8,400,000	8,900,000	5,200,000	-13,200,000	-40,300,000	-2,704,000	2,105,000	-6,247,000	-23,793,000	-1,245,000	3,117,000	-1,636,000	-3,193,000																																			447,000		35,803,000
proceeds from co-tenancy assets at jamalco jv			5,700,000
lower of cost or nrv inventory adjustment											5,100,000	-6,900,000	-6,300,000							4,200,000	3,700,000	23,700,000	13,400,000	3,000,000	2,400,000			30,600,000	9,100,000	0	-3,200,000	3,029,000	0
unrealized (gain) loss on derivative instruments						2,700,000	-6,400,000							-253,000,000	35,500,000		33,100,000	33,100,000	94,400,000		5,900,000	100,000	-3,700,000		-10,100,000	-6,400,000	5,600,000
change in deferred tax benefit						200,000	400,000									10,300,000	6,700,000
asset impairment												0	0
gain on sale of assets				0	0
force majeure settlement
other postretirement benefits gain
change in operating assets and liabilities, net of acquisition:
ravenswood retiree legal settlement																																				0
pbgc settlement								0
proceeds from sale of property, plant and equipment																																								0	0			0	0			10,000	0											15,000								42,000				0				12,000				42,000	0	59,000
acquisition of subsidiary net of cash acquired								-7,900,000	0
debt issuance cost
repayments on casthouse facility
borrowings under iceland term facility
borrowings under vlissingen facility agreement								0
change in cash, cash equivalents, and restricted cash
cash, cash equivalents and restricted cash, beginning of year
cash, cash equivalents and restricted cash, end of year
change in deferred tax expense
proceeds from sales of property, plant and equipment
acquisition of subsidiary, net of cash acquired
borrowings under vlissingen credit facility
century aluminum company
consolidated statements of cash flows
net cash (used) provided by financing activities
supplemental cash flow information:
cash paid for:
interest							2,900,000				4,000,000				1,200,000			9,600,000	16,100,000			10,200,000	800,000		1,000,000	10,200,000	400,000	9,800,000	0
taxes, net of refunds							1,100,000				-400,000
non-cash investing activities:
capital expenditures							6,700,000				3,900,000				4,200,000				1,800,000			-600,000	1,200,000		1,800,000	-1,900,000	4,000,000	1,500,000
free cash flows							-8,100,000				3,700,000				41,600,000				-48,000,000			36,400,000	35,800,000		23,000,000	-6,000,000	-17,500,000	-8,600,000
capitalized interest							2,400,000				1,000,000				1,000,000
distribution of property, plant and equipment to nci
repayment of senior notes due 2025																0	0
early redemption and tender premiums paid																0	0
proceeds from issuance of senior notes due 2028																0	0
proceeds from issuance of convertible senior notes																0	0
repayments under hawesville term loan
purchase of capped calls related to convertible senior notes
deferred tax benefit									-10,900,000	-11,100,000	-1,500,000
debt issuance costs													-100,000	-900,000	-600,000		-100,000																															0	-68,000
repayment of iceland term facility									-3,700,000	-3,700,000	-2,400,000
depreciation and amortization										15,600,000	15,900,000	15,900,000	15,400,000	22,700,000	19,400,000	20,200,000	20,600,000	20,900,000	20,900,000	21,300,000	21,300,000	20,200,000	20,200,000	20,200,000	19,900,000	18,800,000	24,300,000	22,600,000	23,900,000	22,100,000	21,500,000	21,158,000	20,869,000	21,284,000	20,938,000	21,474,000	20,802,000	21,244,000	21,260,000														15,637,000	15,636,000	15,652,000	15,615,000	15,515,000	15,134,000	15,930,000	16,237,000	15,808,000	15,727,000	15,778,000	15,738,000	16,823,000	19,218,000	20,845,000	21,052,000	21,075,000	20,785,000	20,325,000	19,723,000	19,107,000	18,905,000	19,130,000	17,866,000	17,327,000	14,897,000		14,256,000	14,256,000	13,794,000		13,158,000
(gain) loss on derivative instruments												100,800,000
opeb curtailment gain												-900,000
ravenswood pbgc settlement
repayment of senior notes due 2021
proceeds from issuance of senior notes due 2025
debt retirement cost
deferred tax provision													10,400,000	40,600,000	1,300,000
other non-cash items -- net													-3,500,000
accounts receivable -- net													50,100,000
other -- net													-7,100,000
proceeds from sales of property, plant & equipment													0	100,000	0		0				0	0	100,000
repayments on hawesville term loan																	-5,000,000	-5,000,000	-5,000,000
purchases of capped calls related to convertible senior notes																	0
taxes															500,000										0	200,000	100,000	8,500,000	1,000,000
unrealized (gains) losses on forward and derivative contracts
net income on sale of bhh
proceeds from sale of joint venture																								10,300,000	0
borrowings under hawesville term loan
other short-term borrowings																								0	0
repayments on other short-term borrowings
issuance of common stock																								0	0			200,000	0	100,000	100,000	123,000	41,000	197,000	43,000									254,000	23,000	123,000	3,000																							1,543,000				1,973,000	20,000	472,000	581,000	2,380,000	85,000	337,000	37,000	949,000	811,000	5,077,000
debt retirement costs																				0																												0	0
helguvik (gains) losses
net cash (used in) investing activities																												-33,600,000
repayment of debt																				0																								0				0	0							0	0																			-146,000	-145,000	-143,000			-14,365,000	-68,658,000
proceeds from issuance of debt																				0																												0	0
repayment on other short-term borrowings																								0	0
borrowing under hawesville term loan
loss on sale of bhh																									0
borrowing under term loan
repayments on term loan																						-5,000,000	-5,000,000
unrealized (gains) on forward and derivative contracts
ravenswood (gains) losses																																0
borrowings under term loan																								0	0
helguvik
other short term borrowings																											3,400,000
unrealized (gain) loss on forward and derivative contracts																													-700,000	-800,000	-400,000
ravenswood
proceeds from sale of ravenswood																																		0	13,585,000
capital expenditures in accounts payable
cash paid for interest																															200,000
cash paid for taxes																															500,000
unrealized gain on fair value of contingent consideration																																								0	-1,523,000	-10,287,000	-6,527,000
unrealized gain on contingent obligation																																-352,000
bhh impairment
pension and other postretirement benefits																																-4,064,000	768,000	-52,000	1,576,000	1,181,000	337,000	713,000	632,000	-4,693,000	-36,000	722,000	-984,000	5,507,000	-936,000	-245,000	2,613,000	4,414,000	942,000	-5,059,000	1,443,000	2,456,000	933,000	878,000	-1,138,000	2,011,000	-2,160,000	-17,544,000	-11,064,000	2,660,000	3,700,000																					3,214,000		1,877,000
deferred income taxes																																-5,334,000	1,481,000	-662,000	-95,000	7,627,000	-2,007,000	-2,926,000	-3,587,000	-1,393,000	-3,769,000	-3,867,000	8,851,000	-3,869,000	3,771,000															5,603,000	732,000	4,898,000	4,319,000	18,740,000	1,182,000	-518,000	25,548,000	-3,783,000	-50,887,000	-143,682,000	-92,997,000	10,127,000	-57,036,000	8,087,000	-100,118,000	3,582,000	54,550,000	-84,356,000		-14,064,000	19,595,000	6,479,000		-8,891,000
stock-based compensation																																396,000			477,000	368,000	538,000	275,000	321,000	463,000	487,000	489,000	405,000	377,000	424,000	335,000	198,000	117,000	462,000	282,000	217,000	201,000	200,000	67,000	145,000	186,000	169,000	2,013,000	488,000	-1,187,000	929,000	879,000	1,284,000	1,270,000	799,000	1,359,000	-90,000	376,000	3,188,000	8,470,000	2,197,000	1,167,000	1,077,000	1,521,000	979,000	731,000	1,313,000	2,559,000
pension contribution - mt. holly																																								0
purchase of remaining interest in mt. holly smelter																																								0	49,475,000
restricted and other cash deposits																																		-58,000	253,000	-4,000	1,623,000			151,000	141,000	20,730,000	-21,012,000	416,000	1,814,000	-1,999,000	665,000	1,576,000	-2,295,000							0	0			18,851,000	-12,662,000	-490,000	-493,000	-510,000				-7,812,000			-6,000	1,145,000	-1,000	2,600,000	1,415,000
repurchase of common stock																																								0	0	-16,913,000	-19,439,000									0	0	0	-4,033,000	-7,085,000
change in cash and cash equivalents																																-7,002,000	43,540,000	4,778,000	-6,508,000	14,810,000	-11,791,000	2,923,000	11,068,000	-7,583,000	-44,432,000	-59,023,000	63,189,000	29,832,000	72,026,000	8,886,000	-31,590,000	-56,713,000	13,270,000	-67,940,000	11,495,000	10,601,000	16,863,000	-26,033,000	-856,000	-32,994,000	-16,006,000	-61,086,000	-10,809,000	39,053,000	8,979,000	42,525,000	15,505,000
cash and cash equivalents, beginning of year
cash and cash equivalents, end of year
unrealized loss on forward and derivative contracts																																	-939,000	-6,121,000	13,978,000
equity in earnings of joint ventures, net of dividends																																	-214,000	248,000	-393,000					1,263,000	-704,000			1,086,000	-285,000
cash and cash equivalents, beginning of period																																	0	0	132,403,000		0	0	115,393,000		0	0	163,242,000		0	0	84,088,000																																	0	0	44,168,000
cash and cash equivalents, end of period																																	43,540,000	4,778,000	125,895,000		-11,791,000	2,923,000	126,461,000		-44,432,000	-59,023,000	226,431,000		72,026,000	8,886,000	52,498,000																																	20,673,000	-17,589,000	52,763,000
unrealized gain on e.on contingent obligation																																		-353,000	-353,000	-352,000	-353,000	-353,000	-353,000	-352,000	-353,000	-353,000	-353,000	-353,000	-353,000	-353,000	-353,000	-353,000	-353,000	-353,000	-15,722,000
lower of cost or market inventory adjustment																																			-3,880,000	-2,159,000	2,370,000	4,913,000	-5,784,000	-23,474,000	5,324,000			0	0	-140,000	-1,107,000	-9,039,000	-5,763,000	10,211,000	5,838,000	0	-8,201,000	5,434,000	-17,051,000	6,303,000	13,479,000	123,000	-139,000	-125,000	-7,300,000	7,056,000	-57,000	-6,658,000	-2,307,000	-40,458,000	2,271,000
gain on remeasurement of equity investment
helguvik impairment
ravenswood impairment																																				0				0	0
sebree power contract amortization																																												0	0	0	-5,534,000	-16,570,000
purchase of sebree smelter																																												0				0	0
equity in earnings of joint ventures																																					-155,000	-379,000	-357,000
gain on bargain purchase																																																0	-3,211,000
depreciation																																								24,302,000	19,406,000	18,278,000	18,131,000	17,947,000	17,641,000	17,375,000	17,768,000	17,488,000			15,688,000
accounts receivable — net																																								-863,000	2,696,000	-6,343,000	72,702,000	-25,589,000	1,677,000	-6,635,000	10,566,000	-4,938,000	32,820,000	-31,885,000	-1,998,000	-5,857,000	27,609,000	-21,405,000	-2,884,000
other — net																																								2,480,000	3,321,000	-8,328,000	-604,000	6,103,000	-917,000	-2,560,000	64,000	15,246,000	-11,538,000	11,335,000	2,558,000	13,780,000	-12,880,000	369,000	335,000
investments in and advances to joint ventures																																																				0	-75,000	-100,000	-100,000	-100,000				0	-15,000	-7,000	-10,000	-6,000	-15,000
accrued and other plant curtailment costs — net																																									0	1,072,000	1,077,000	1,083,000	1,086,000	1,089,000	1,092,000	1,072,000	1,112,000	1,114,000	1,154,000	1,226,000	1,244,000	1,407,000	1,374,000
debt discount amortization																																									98,000	96,000	95,000	93,000	91,000	89,000	88,000	86,000	84,000	223,000	279,000	278,000	268,000	267,000	256,000	256,000	246,000	534,000	821,000	811,000	791,000	782,000	766,000
nordural expansion — helguvik																																									-55,000	-102,000	-73,000	-60,000	-91,000	-93,000	-93,000	-476,000	-296,000	-814,000	-1,745,000	-1,843,000
purchase of carbon anode assets and improvements																																									-4,698,000	-3,012,000	-1,594,000	-950,000	-5,054,000	-1,502,000	-5,724,000	-9,694,000	-4,849,000	-3,520,000	-150,000
equity in (earnings) losses of joint ventures, net of dividends																																											-510,000				495,000
unrealized net gain on forward contracts																																																																																				-1,947,000
gain on fair value of contingent consideration
payments received from joint ventures
repayment of contingent obligation																																																								0	0
borrowings under revolving credit facility																																																6,000,000				0	0	0	18,076,000	0
repayments under revolving credit facility																																																				0	0	0	-18,076,000	0									0	0	-25,000,000
unrealized net (gain) loss on forward contracts																																																	-365,000	-256,000	-141,000																			395,930,000				-27,399,000
undistributed earnings of joint ventures																																																	-731,000	-436,000	-951,000	-507,000	-1,126,000	-349,000	-641,000	-859,000	-907,000	-460,000	-1,219,000	-793,000	-1,183,000			-867,000	-570,000			-2,507,000	-5,566,000	-4,393,000	-4,294,000	-3,737,000
dividends and payments received on advances from joint ventures
issuance of common stock — net																																																	0
cash and cash equivalents, beginning of the period																																																	0	0	183,976,000		0	0	183,401,000		0	0	304,296,000		0	0	198,234,000											96,365,000
cash and cash equivalents, end of the period																																																	13,270,000	-67,940,000	195,471,000		16,863,000	-26,033,000	182,545,000		-16,006,000	-61,086,000	293,487,000		8,979,000	42,525,000	213,739,000											168,124,000
proceeds from the sale of property, plant and equipment																																																			353,000	99,000	21,000	10,000	58,000		1,415,000
realized benefit of contractual receivable
non-cash loss on early extinguishment and modification of debt
non-cash contingent obligation
net change in restricted cash
unrealized net income on forward contracts																																																					19,000	-1,778,000	4,955,000				4,715,000	5,574,000			1,853,000	10,276,000	-834,000	697,000	1,817,000	68,455,000			209,024,000	51,839,000			270,315,000			286,138,000				22,269,000
non-cash loss on early extinguishment of debt																																																									0														0	0								0
purchase of carbon anode assets																																																					339,000
payments received on advances from joint ventures																																																					0	0	3,166,000
nordural expansion																																																						-1,640,000	-1,946,000	-2,547,000	-2,367,000	-3,917,000	-4,051,000	-4,128,000	-4,986,000	-5,435,000	-4,678,000	-4,375,000	-5,474,000	-5,631,000	-6,501,000	-20,749,000	-25,259,000	-7,389,000	-9,204,000	-20,579,000	-29,806,000	-29,175,000	-37,755,000	-46,754,000	-40,233,000	-68,769,000	-79,445,000	-86,987,000	-64,666,000	-48,988,000	-42,302,000
repayments of debt
issuance of common stock – net																																																									51,000				0				0
unrealized gain on contractual receivable																																																															-88,000
write-off of intangible asset																																																																0
non-cash income from disposition of equity investments
sale of short-term trading securities																																																																0	0	0	13,686,000	2,652,000	218,314,000	127,450,000
payment received on advances from joint ventures
financing fees																																																																															0	-515,000	0	-4,617,000	-257,000
accrued and other plant curtailment costs – net																																																									1,569,000	-6,968,000	-9,624,000		-729,000	-304,000	-2,272,000
gain on disposal of assets
changes in operating assets and liabilities:
accounts receivable – net																																																									2,771,000	-18,455,000	7,520,000		-2,286,000	-1,301,000	2,314,000		-10,052,000	-92,000	26,342,000	-21,361,000	5,314,000	-6,356,000		11,026,000						-15,640,000				-8,202,000		-2,078,000
other – net																																																									-13,480,000	2,459,000	-2,998,000		-2,695,000	1,320,000	-6,093,000		510,000	4,936,000	-20,000	-2,909,000	-632,000	-1,460,000		3,466,000						-2,838,000				-5,148,000		6,115,000
payments received on advances to joint ventures																																																									0
realized benefit on contractual receivable																																																													15,130,000	16,825,000	15,368,000
unrealized net gain on contractual receivable
1.
goodwill impairment
non-cash loss on early extinguish and modification of debt
purchase of short-term trading securities																																																																				0	11,004,000	-108,536,000
purchase of property, plant, and equipment
repayment of long-term debt – related party
repayment under revolving credit facility
excess tax benefits from share-based compensation																																																																				0	-158,000	-499,000	-72,000	-29,000	-157,000	-330,000	-150,000	-154,000
issuance of preferred stock
(gain) loss on disposal of assets																																																																				139,000			118,000	46,000			-6,894,000	-2,000				-16,000	27,000	-31,000
non-cash gain on early extinguishment of debt
pension and other post retirement benefits																																																															3,666,000	2,231,000	3,226,000	3,383,000	4,112,000		4,336,000	4,177,000	6,189,000	-3,408,000	4,764,000	5,143,000	3,556,000	3,866,000	3,636,000	3,503,000		3,832,000
undistributed (earnings) losses of joint ventures																																																															-1,105,000
borrowings of long-term debt																																																																							0	0	0	30,000,000
repayment of long-term debt																																																																								-34,636,000	-285,151,000	-29,649,000
change in cash
cash, beginning of year
cash, end of year
accrued plant curtailment costs																																																																	-8,095,000	2,816,000	18,235,000
equity investment impairment																																																																	0
repayments of long-term debt – related party
excess tax benefits from shared-based compensation																																																																				0	158,000	499,000		29,000	157,000	330,000		154,000	235,000	855,000
net change in cash																																																																	-33,694,000	-37,461,000	138,092,000	-222,589,000	246,094,000	44,588,000		-122,951,000
cash, beginning of the period																																																																	0	0	129,400,000	0	0	60,962,000		0
cash, end of the period																																																																	-33,694,000	-37,461,000	267,492,000	-222,589,000	246,094,000	105,550,000		-122,951,000
undistributed losses (earnings) of joint ventures																																																																			887,000
issuance of common stock – net of issuance costs																																																																			104,041,000	441,311,000				-1,068,000
accounts payable – trade																																																																						12,797,000								4,724,000				-3,175,000
investments in joint ventures
workers’ compensation
prepaids and other current assets																																																																														-3,398,000		3,275,000	-4,317,000	-1,395,000		1,448,000
business acquisitions, net of cash acquired																																																																															0	0
proceeds from sale of property, plant, and equipment
repayment of long-term debt – third party
net borrowings (repayments) under credit facility
dividends																																																																															0	0			0	0
increase in short-term investments – net																																																																								-137,046,000
net repayments under revolving credit facility																																																																												0
loss on disposal of assets																																																																										180,000										24,000
net change in cash and cash equivalents																																																																										71,759,000		20,919,000	11,663,000	-240,000
repayment of long-term debt - third party
repayment of long-term debt - related party
net borrowings (repayments) under revolving credit facility
accounts payable - trade																																																																												-74,000
purchase of other property, plant and equipment																																																																												-3,042,000	-4,936,000	-2,632,000		-4,148,000	-2,941,000	-2,540,000
borrowings																																																																												20,000,000	10,000,000	59,000,000		43,559,000	40,053,000	105,325,000	314,000
cash and cash equivalents at the beginning of the period																																																																												0
cash and cash equivalents at the end of the period																																																																												20,919,000	11,663,000	17,512,000
restricted cash deposits																																																																													0	-4,001,000	0	0
excess tax benefit from share-based compensation																																																																														-855,000
net borrowings under revolving credit facility																																																																														-2,969,000
cash and cash equivalents at the beginning of the year																																																																														17,752,000
repayment of long-term debt — third party
repayment of long-term debt — related party
net borrowing under revolving credit facility
increase in cash
repayment of third party debt
repayment of related party debt
net increase in cash and cash equivalents																																																																																20,673,000	-17,589,000	8,595,000
accounts payable — trade
inventory market adjustment																																																																																				0
repayment of debt — third party
repayment of debt — related party
minority interest
cumulative effect of change in accounting principle
acquisitions, net of cash acquired																																																																																				0
repayment of debt – third party
repayment of debt – related party
net increase in cash																																																																																				1,305,000
cash, beginning of period																																																																																				0
cash, end of period																																																																																				1,305,000
allocation of purchase price:
current assets																																																																																				0
property, plant and equipment																																																																																				0
goodwill																																																																																				0
current liabilities																																																																																				0
long-term debt																																																																																				0
other non-current liabilities																																																																																				0
total purchase price																																																																																				0

The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.